In the wake of mounting evidence about the connection between oral health and overall health, The Guardian Life Insurance Company of America (Guardian), New York, has announced that it will offer coverage for ViziLite(R) Plus with TBlue630(TM), an oral cancer screening technology that can detect early signs of oral cancer. ViziLite Plus with TBlue630 can dramatically increase chances of survival. Guardian is one of the first benefits providers to offer ViziLite Plus coverage nationally through a dental PPO network.
Oral cancer claims the life of one American every hour, according to The American Cancer Society. However, when oral cancer is detected early, treatment is 90% successful and less costly. The ViziLite Plus exam is fast and painless, and can help save lives.
ViziLite Plus with TBlue630 helps dentists identify abnormal oral tissue with lumenoscopy technology. The advanced light technology enables dentists to detect abnormalities that the naked eye can't see.
"Guardian has been at the forefront of promoting effective, affordable, preventive dental care," said John Foley, vice president, Guardian Group Dental and Chairman of the Board for the National Association of Dental Plans (NADP). "While incidences of many cancers have been on the decline, the incidence of oral cancer has increased. Risk factors for oral cancer include smoking, heavy drinking and genetics. Those over age 40 are most vulnerable. But according to the New York County Dental Society (NYCDS) and OralScan Laboratories, 25% of oral cancers occur in people with no lifestyle risk factors. We are pleased to offer the cutting-edge ViziLite Plus screening technology in the fight against oral cancer."
